Skip to main content
. 2025 Dec 26;27(1):269. doi: 10.3390/ijms27010269
FD Fabry disease
GLA Galactosidase alpha
Gb3 Globotriaosylceramide
Lyso-Gb3 Globotriaosylsphingosine
ESKD End-stage kidney disease
VUS Variants of unknown significance
AS Alport syndrome
GBM Glomerular basement membrane
XLAS X-linked Alport syndrome
ADAS Autosomal dominant Alport syndrome
ARAS Autosomal recessive Alport syndrome
AMI Acute myocardial infarction
ERT Enzyme replacement therapy
ACE Angiotensin-converting enzyme
MRI Magnetic resonance imaging
IVS Interventricular septum
PNS Peripheral nervous system
eGFR Estimated glomerular filtration rate